| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 11, 2024 | Nov 13, 2024 | Emergent BioSolutions Inc. | Director | Sell | 22.5 | -14,287 | -20.89% | ✗ | $171K |
| Jun 14, 2019 | Jun 14, 2019 | Aptevo Therapeutics Inc. | CEO | Buy | 91.3 | +50,000 | 20.53% | ✗ | $44K |
| May 20, 2019 | May 20, 2019 | Aptevo Therapeutics Inc. | CEO | Buy | 91.3 | +30,000 | 14.04% | ✗ | $24.3K |
| May 14, 2019 | May 14, 2019 | Aptevo Therapeutics Inc. | CEO | Buy | 82.5 | +10,000 | 4.91% | ✗ | $7.8K |
| Dec 4, 2018 | Dec 6, 2018 | Aptevo Therapeutics Inc. | CEO | Buy | 86.3 | +10,000 | 5.17% | ✗ | $23.8K |
| May 21, 2018 | May 23, 2018 | Aptevo Therapeutics Inc. | CEO | Sell | 26.3 | -8,373 | -4.15% | ✗ | $47K |
| Mar 19, 2018 | Mar 21, 2018 | Aptevo Therapeutics Inc. | CEO | Buy | 97.5 | +100,000 | 150.76% | ✗ | $293K |
| Mar 19, 2018 | Mar 21, 2018 | Aptevo Therapeutics Inc. | CEO | Buy | 97.5 | +100,000 | 150.76% | ✗ | $293K |
| Mar 7, 2016 | Mar 9, 2016 | Emergent BioSolutions Inc. | Director | Sell | 17.5 | -33,134 | -17.95% | ✗ | $1.2M |